Preclinical and randomized clinical evaluation of the p38α kinase inhibitor neflamapimod for basal forebrain cholinergic degeneration
对 p38α 激酶抑制剂 neflamapimod 治疗基底前脑胆碱能变性的临床前和随机临床试验进行评估
期刊:Nature Communications
影响因子:14.7
doi:10.1038/s41467-022-32944-3
Ying Jiang # ,John J Alam # ,Stephen N Gomperts ,Paul Maruff ,Afina W Lemstra ,Ursula A Germann ,Philip H Stavrides ,Sandipkumar Darji ,Sandeep Malampati ,James Peddy ,Cynthia Bleiwas ,Monika Pawlik ,Anna Pensalfini ,Dun-Sheng Yang ,Shivakumar Subbanna ,Balapal S Basavarajappa ,John F Smiley ,Amanda Gardner ,Kelly Blackburn ,Hui-May Chu ,Niels D Prins ,Charlotte E Teunissen ,John E Harrison ,Philip Scheltens ,Ralph A Nixon